Key considerations in designing ADCs to minimize resistance development
19 Feb 2025
Antibody Drug Conjugates
- What are the key considerations for target selection to enhance ADC efficacy?
- What should be the payload and linker strategy to minimize resistance initiation?
- How to monitor and manage resistance (including combination strategy and targeting multiple pathways)?
- Should we be considering patient stratification to minimize resistance development?
Industry Expert
